The Real Cost of Being Underinsured in India — Three Scenarios With Actual Numbers

"I have health insurance" is a sentence that means less than most people think. Whether it's adequate or inadequate is the real question — and the gap between those two states is often discovered only at the worst possible moment: when a family member is hospitalised and the bills start arriving.

This guide puts specific numbers on the cost of being underinsured — because it's not an abstract risk. It's a calculable one.

Why India's Underinsurance Problem Is Getting Worse, Not Better

Medical inflation in India runs at approximately 14% annually — per Oneassure.in's premium inflation guide. This is not general consumer inflation. It is specific to hospital rooms, surgical procedures, specialist fees, diagnostic imaging, and medication.

At 14% annual medical inflation:

A family that bought a ₹10 lakh health plan in 2020 and never increased the sum insured now holds what is effectively ₹4.7 lakh of 2020 coverage — because the other ₹5.3 lakh has been eroded by medical cost growth.

Per BusinessToday.in's December 2025 insurance review: "That ₹3 lakh policy that felt adequate in 2020 might barely cover three days of hospitalisation today."

Scenario 1 — The ₹5 Lakh Health Plan and a Cardiac Stent Procedure

Profile: Rahul, 44 years old, Noida Sector-62. Works in IT. Has a ₹5 lakh family floater with a plan he bought in 2018. Hasn't upgraded it.

Event: Rahul is diagnosed with a single-vessel coronary artery blockage. His cardiologist recommends a percutaneous coronary intervention (PCI) — stent placement — at a private hospital in Noida.

Actual costs at a mid-tier private Noida hospital in 2026:

Per standard NCR cardiology procedure costs from hospital websites and published treatment data:

• Hospital admission (2 nights): ₹18,000–30,000
• Cardiologist/interventional cardiologist fee: ₹40,000–75,000
• Catheterisation lab charges: ₹60,000–90,000
• Drug-eluting stent (single): ₹35,000–90,000 (depending on type)
• Anaesthesia and OT charges: ₹20,000–40,000
• Pre-procedure diagnostics (echo, angiography, blood work): ₹25,000–45,000
• Medications: ₹8,000–15,000
• Total: ₹2,06,000 to ₹3,85,000 for a single-vessel stent

At ₹5 lakh SI, Rahul's policy covers this fully — for a basic single-vessel intervention.

But: If Rahul also has diabetes (likely at 44 with a cardiac event) and develops a post-procedure complication requiring extra days in hospital — or if two vessels need treatment — the bill moves toward ₹5–6 lakh easily.

The ₹5 lakh exhaustion scenario: If Rahul files this claim, his ₹5 lakh sum insured is mostly or entirely used. If he or his wife needs hospitalisation later in the same policy year, there is zero coverage left — unless the plan has a restoration benefit.

The underinsurance lesson: ₹5 lakh is adequate for a simple, uncomplicated procedure at a mid-tier Noida hospital in 2026. It is inadequate for a complex presentation, a multi-vessel event, or any event requiring follow-up hospitalisation in the same year.

Scenario 2 — The ₹10 Lakh Plan and a Cancer Diagnosis

Profile: Sunita, 51 years old, Greater Noida. Has a ₹10 lakh individual health plan. She and her husband feel this is "really good coverage."

Event: Sunita is diagnosed with Stage 2 breast cancer. Her oncologist recommends surgery (modified radical mastectomy), followed by 6 cycles of chemotherapy and radiation.

Actual cost breakdown:

Per HCG Oncology's verified chemotherapy cost guide (April 2026) and Shifamhealth.com's cancer treatment cost guide:

• Modified radical mastectomy: ₹3,00,000–₹5,00,000
• Chemotherapy (6 cycles of AC-T regimen): ₹25,000–₹80,000/cycle = ₹1,50,000–₹4,80,000 total
• Radiation therapy (25 sessions): ₹1,00,000–₹4,50,000 total
• Targeted therapy (if HER2+): ₹80,000–₹1,20,000/dose, 17 doses = ₹13,60,000–₹20,40,000 for a full course
• Diagnostics, pathology, genetic testing: ₹80,000–₹1,50,000
• Total for hormone-receptor-positive breast cancer (without targeted therapy): ₹6–12 lakh
• Total for HER2-positive breast cancer (with targeted therapy): ₹18–30 lakh

The ₹10 lakh outcome:

For a hormone-receptor-positive case: The ₹10 lakh plan covers the full course of surgery + chemotherapy + radiation. Zero gap for this presentation.

For a HER2-positive case: The ₹10 lakh plan covers the first ₹10 lakh of a ₹20–30 lakh treatment. Sunita's family is personally liable for ₹10–20 lakh — at a time when Sunita cannot work and the household is under maximum financial and emotional stress.

The underinsurance lesson: ₹10 lakh is adequate for many cancers at standard presentations. It is completely inadequate for HER2-positive breast cancer, blood cancers, or any cancer requiring targeted therapy or bone marrow transplant. Adequate coverage for cancer in 2026 is ₹25–50 lakh, or a base plan supplemented by a standalone cancer or critical illness policy.

Scenario 3 — The No-Life-Insurance Family and the Primary Earner

Profile: Amit, 38 years old, Noida Sector-137. Annual income ₹24 lakh. Married with two children aged 8 and 11. Outstanding home loan ₹65 lakh. Parents in Lucknow receive ₹6 lakh/year in support. No term insurance — "I'm young and healthy."

Event: Amit dies unexpectedly from a sudden cardiac arrest.

The financial picture the day after:

• Monthly home loan EMI: ₹55,000–60,000 — now unserviceable
• Monthly household expenses for spouse and children: ₹80,000–1,00,000
• Annual parent support: ₹6 lakh now falls on no one
• Children's education (school fees, college in 7–9 years): ₹50–80 lakh for both through graduation

The bank's position: The home loan doesn't disappear. The bank will proceed with NPA declaration and eventually recovery proceedings within 90–180 days if EMIs are missed. The family may need to sell the home — at potentially distressed prices — to clear the loan.

What ₹2 crore term insurance would have cost: Per Ditto's STPP review (September 2026): approximately ₹17,222/year for a 25-year-old — and perhaps ₹24,000–30,000/year for a 38-year-old buying Axis Max Life STPP for ₹2 crore. Post-GST removal in September 2025, the annual cost is approximately ₹20,000–25,000.

What ₹2 crore pays Amit's family:

• ₹65 lakh clears the home loan
• ₹1.35 crore invested conservatively at 7% generates ₹9.45 lakh/year — not Amit's full income but enough to sustain the household and support the parents while Amit's spouse rebuilds financial independence

The underinsurance lesson: The difference between "I don't have life insurance" and "I have ₹2 crore life insurance" is approximately ₹20,000–25,000/year. For a person earning ₹24 lakh annually, that's about 1% of income. The consequence of not paying that 1% could be losing the family home.

Why Underinsurance Persists Despite the Math Being Obvious

Anchoring to Past Premiums

Families who bought ₹3 lakh coverage in 2015 are anchored to the idea that they have health coverage. Upgrading feels like paying more for the same thing. It isn't — it's paying to maintain the same real protection level.

The "I'm Healthy" Bias

Young, healthy earners consistently underestimate the probability of serious illness and consistently overestimate the lead time before a health event. Cardiac events, cancer diagnoses, and major accidents don't wait for a convenient moment.

Per Kotak Life's financial review checklist (February 2026): "In 2026, with hospital costs surging, a room rent cap can eat into your claim amount drastically due to proportionate deduction clauses."

The Premium Anchoring Effect

Insurance feels expensive until it's needed. A ₹25,000/year health plan premium feels large. A ₹15 lakh hospital bill from a partially insured cancer diagnosis makes ₹25,000/year feel trivial in retrospect.

What "Adequately Insured" Looks Like in Noida in 2026

Health insurance: ₹25 lakh sum insured for a working adult (₹15 lakh minimum). ₹50 lakh for a family floater covering two adults. No room rent cap. No mandatory co-payment. Restoration benefit for multiple hospitalisations.

Term insurance: 15–20x annual income, adjusted for outstanding liabilities. For a ₹24 lakh earner: ₹3.6–4.8 crore, reduced to ₹2–3 crore as loans are paid down.

Critical illness rider: ₹20–50 lakh standalone payout on diagnosis, separate from life cover. Covers income loss during 6–18 months of treatment.

Review annually: At 14% medical inflation, "adequate" in 2026 becomes "inadequate" by 2028 unless sum insured is actively managed.

For an underinsurance assessment and coverage gap analysis for your Noida family, call Policywings at +91-98111-67809.

Sources: Oneassure medical inflation guide, BusinessToday December 2025 checklist, HCG Oncology chemo cost guide (April 2026), Shifamhealth cancer cost guide, Ditto STPP review (September 2026), Kotak Life financial review (February 2026).

Policywings Insurance Broking Pvt. Ltd. | IRDAI License No. DB 835 | A-57, 5th Floor, Sector-136, Noida | +91-98111-67809